Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device
Navidea Biopharmaceuticals Inc.
Post-Effective Amendment to Registration Statement (Form POS AM)
01/28/2022 | News release | Distributed by Public on 01/28/2022 10:13
Please select the service you want to use:
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact